Methods for treating autoimmune and chronic inflammatory conditions using antagonists of CD30 or CD30L

Details for Australian Patent Application No. 2001281163 (hide)

Owner Immunex Corporation

Inventors Mohler, Kendall M.; Barone, Dauphine S.; Kennedy, Mary K; Pluenneke, John D.; Peschon, Jacques J.

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2001281163

PCT Pub. Number WO02/11767

Priority 60/224,079 08.08.00 US

Filing date 6 August 2001

Wipo publication date 18 February 2002

Acceptance publication date 30 March 2006

International Classifications

A61K 47/00 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives

Event Publications

30 March 2006 Application Accepted

  Published as AU-B-2001281163

3 August 2006 Standard Patent Sealed

28 February 2008 Section 223 Application Received

  Immunex Corporation An application to extend the time from 03 Dec 2004 to 03 Jan 2008 in which to file search results has been filed . Address for service in Australia - Phillips Ormonde & Fitzpatrick Level 22 367 Collins Street Melbourne VIC 3000 2002

17 April 2008 Section 223 Application Allowed

  Immunex Corporation The time in which to file search results has been extended to 03 Jan 2008. Address for service in Australia - Phillips Ormonde & Fitzpatrick Level 22 367 Collins Street Melbourne VIC 3000 2002

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2001281164

2001281162